Tag:
Tovaxin
Latest Headlines
Latest Headlines
Opexa shares skyrocket on Ph3 MS progress
Shares of Opexa Therapeutics shot up more than 60 percent this morning--taking a big gain on a relatively modest step forward on its new MS therapy Tovaxin. The developer says that it successfully
Opexa shares in meltdown
On Friday Opexa Therapeutics announced that its lead therapy--the MS drug Tovaxin--failed a Phase IIb trial with 150 patients. Researchers said that the therapy demonstrated a positive trend in
